Today, Taj Pharma has 4000+ products approved by the FDA to manufacture. We have a highly independent regulatory team ready to assist and ensure the registration of your products of prescription drugs, controlled substances, biological products, medical supplies and food supplements to be available in the global market. Taj Pharmaceuticals been in the business for […]
- Bacteria & Viruses
- Conferences & Events
- COVID-19
- Disease Info
- Disease Trends
- Divisional News
- Drug Approvals
- Drug News
- Eating Habits
- Generic
- Global Agenda
- Health & Disease
- Health & Fitness
- Health Care
- Health Kiosk
- Health News
- Healthy Food
- Industry News
- Infectious Disease
- Interactive Media
- Media
- Medical News
- Mental Health
- Press Release
Dexamethasone is a type of corticosteroid medication manufactured by Taj Pharmaceuticals India. It is used in the treatment of many conditions, including COVID-19 respiratory side effects, rheumatic problems, a number of skin diseases, severe allergies, asthma, chronic obstructive lung disease, croup, brain swelling, eye pain following eye surgery, and along with antibiotics in tuberculosis. In adrenocortical insufficiency, it should be used together with a medication that has greater mineralocorticoid effects such as fludrocortisone. In preterm labor, it may be used to improve outcomes in the baby. It may be taken by mouth, as an injection into a muscle, or intravenously. The effects of dexamethasone are frequently seen within a day and last for about three days.
Ranitidine is a commonly prescribed medicine for countering acidity and is on the WHO’s Model List of Essential Medicines. Amid a raging controversy over commonly used heartburn drug Ranitidine, Mumbai-based Taj Pharmaceuticals Limited today said that its formulation drug is safe. The company said that the test results found that Taj Pharmaceuticals’ Ranitidine tablets was within […]
It might be difficult to implement compulsory prescription of generics The enforcement by the drug regulator will not be easy given the shortage of drug inspectors – {Taj Pharmaceuticals Generic Drug Division} Prime Minister Narendra Modi wants to defeat the doctor-pharmaceutical company nexus and make medicines affordable by making it compulsory to prescribe drugs in […]
- Bacteria & Viruses
- Conferences & Events
- Corporate News
- COVID-19
- Current Events
- Disease Info
- Disease Trends
- Divisional News
- Drug Approvals
- Drug News
- Eating Habits
- Global Agenda
- Health & Disease
- Health & Fitness
- Health Care
- Health Kiosk
- Health News
- Healthy Food
- Herbal Trends
- Industry News
- Infectious Disease
- Interactive Media
- Local News
- Media
- Medical News
- Mental Health
- Oncology News
- Press Release
Taj Pharma India | Taj Pharmaceuticals India | Taj Pharma | Taj Pharma Hyderabad | Taj Pharma Mumbai | Taj Pharma Bombay | Taj Pharma News | Taj Pharma India News | Taj Pharma Updates | Taj Pharma Products | Taj Pharmaceuticals Products | Taj Pharma Owner | Taj Pharma CEO | Taj Pharmaceuticals CEO | Taj Pharma Jobs | Taj Pharma Vacancy | Taj Pharma Review | Taj Pharma Director
- Bacteria & Viruses
- Cancer
- Conferences & Events
- Corporate News
- COVID-19
- Current Events
- Disease Info
- Disease Trends
- Divisional News
- Drug Approvals
- Drug News
- Eating Habits
- Generic
- Global Agenda
- Health & Disease
- Health & Fitness
- Health Care
- Health Kiosk
- Health News
- Healthy Food
- Herbal Trends
- Industry News
- Infectious Disease
- Interactive Media
- Local News
- Media
- Medical News
- Mental Health
- Oncology News
- Press Release
#TajPharma #TajPharmaIndia #TajPharmaceuticalsIndia #TajPharmaHyderabad #TajPharmaMumbai #TajPharmaceuticalsProducts #TajPharmaOwner #TajPharmaCEO #TajPharmaceuticalsCEO #TajPharmaGujarat